BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21422850)

  • 1. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years.
    Steiner AZ; Herring AH; Kesner JS; Meadows JW; Stanczyk FZ; Hoberman S; Baird DD
    Obstet Gynecol; 2011 Apr; 117(4):798-804. PubMed ID: 21422850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
    Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
    JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary follicle-stimulating hormone as a measure of natural fertility in a community cohort.
    Steiner AZ; Long DL; Herring AH; Kesner JS; Meadows JW; Baird DD
    Reprod Sci; 2013 May; 20(5):549-56. PubMed ID: 23171685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study.
    Hagen CP; Vestergaard S; Juul A; Skakkebæk NE; Andersson AM; Main KM; Hjøllund NH; Ernst E; Bonde JP; Anderson RA; Jensen TK
    Fertil Steril; 2012 Dec; 98(6):1602-8.e2. PubMed ID: 22959460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of ovarian reserve as predictors of future fertility.
    Harris BS; Jukic AM; Truong T; Nagle CT; Erkanli A; Steiner AZ
    Fertil Steril; 2023 Jan; 119(1):99-106. PubMed ID: 36460524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between diminished ovarian reserve and luteal phase deficiency.
    Pfister A; Crawford NM; Steiner AZ
    Fertil Steril; 2019 Aug; 112(2):378-386. PubMed ID: 31056309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
    Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
    Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
    Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
    Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimüllerian hormone serum levels: a putative marker for ovarian aging.
    de Vet A; Laven JS; de Jong FH; Themmen AP; Fauser BC
    Fertil Steril; 2002 Feb; 77(2):357-62. PubMed ID: 11821097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts.
    Katz-Jaffe MG; Surrey ES; Minjarez DA; Gustofson RL; Stevens JM; Schoolcraft WB
    Obstet Gynecol; 2013 Jan; 121(1):71-7. PubMed ID: 23262930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early follicular phase serum FSH as a function of age: the roles of inhibin B, inhibin A and estradiol.
    Burger HG; Dudley E; Mamers P; Groome N; Robertson DM
    Climacteric; 2000 Mar; 3(1):17-24. PubMed ID: 11910605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body size affects measures of ovarian reserve in late reproductive age women.
    Su HI; Sammel MD; Freeman EW; Lin H; DeBlasis T; Gracia CR
    Menopause; 2008; 15(5):857-61. PubMed ID: 18427357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
    Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
    J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
    van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
    Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.